Collegium Pharmaceutical Inc (COLL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	1.87% 205.45	209.36	188.00	177.76	159.30
Cost Of Revenue	3.89% 77.07	80.19	79.62	80.43	62.51
Gross Profit	0.61% 128.38	129.17	108.38	97.32	96.79
Operating Expenses	0.80% 67.62	67.08	73.28	75.64	61.95
Benefits Costs and Expenses	6.32% 176.41	165.93	170.97	174.63	143.72
Costs And Expenses	6.32% 176.41	165.93	170.97	174.63	143.72
Operating Income/Loss	2.14% 60.76	62.09	35.10	21.69	34.84
Income/Loss From Continuing Operations Before Tax	33.15% 29.04	43.44	17.02	3.122	15.58
Income Tax Expense/Benefit, Deferred	16.98% -10.07	-12.13	-2.914	-0.539	-8.733
Income Tax Expense/Benefit	1.21% 12.07	11.93	5.042	0.705	6.245
Income/Loss From Continuing Operations After Tax	46.16% 16.96	31.51	11.98	2.417	9.335
Net Income/Loss	46.16% 16.96	31.51	11.98	2.417	9.335
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.26% 31.65	31.57	31.81	31.79	32.26
Diluted Average Shares	1.61% 40.08	39.44	39.08	32.84	40.16
Basic Earnings Per Share	46.00% 0.54	1.00	0.38	0.08	0.29
Diluted Earnings Per Share	45.24% 0.46	0.84	0.34	0.07	0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ELAN

$22.94

1.15%

RGC

$23.23

3.21%

RDY

$14.13

1.53%

NBIX

$129.78

1.57%

VTRS

$13.51

2.10%

UTHR

$536.12

0.62%